.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
McKesson
Cantor Fitzgerald
Accenture
Harvard Business School
Medtronic
Teva
Colorcon
Merck
Mallinckrodt

Generated: December 15, 2017

DrugPatentWatch Database Preview

HEPARIN SODIUM Drug Profile

« Back to Dashboard

When do Heparin Sodium patents expire, and when can generic versions of Heparin Sodium launch?

Heparin Sodium is a drug marketed by Abraxis Pharm, Akorn, Chamberlin Parenterl, Dell Labs, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Hospira Inc, Lilly, Luitpold, Organon Usa Inc, Parke Davis, Pfizer, Pharm Spec, Pharmacia And Upjohn, Sagent Pharms, Sandoz, Shenzhen Techdow, Smith And Nephew, Solopak, Watson Labs, Watson Labs Inc, West-ward Pharms Int, Baxter Hlthcare, Mcgaw, B Braun, and Pharma Serve Ny. and is included in fifty-eight NDAs.

The generic ingredient in HEPARIN SODIUM is heparin sodium. There are seventy-seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Drug patent expirations by year for HEPARIN SODIUM

Pharmacology for HEPARIN SODIUM

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Smith And NephewHEPARIN SODIUMheparin sodiumINJECTABLE;INJECTION088239-001Jul 26, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntHEPARIN SODIUMheparin sodiumINJECTABLE;INJECTION017007-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Organon Usa IncHEPARIN SODIUMheparin sodiumINJECTABLE;INJECTION000552-009Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HospiraHEPARIN SODIUMheparin sodiumINJECTABLE;INJECTION040095-001Jul 26, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HospiraHEPARIN SODIUM PRESERVATIVE FREEheparin sodiumINJECTABLE;INJECTION005264-014Apr 7, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsHEPARIN SODIUMheparin sodiumINJECTABLE;INJECTION017064-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HospiraHEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5%heparin sodiumINJECTABLE;INJECTION018911-007Jan 30, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HospiraHEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9%heparin sodiumINJECTABLE;INJECTION018911-004Jan 30, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
PfizerHEPARIN SODIUMheparin sodiumINJECTABLE;INJECTION201370-002Jul 21, 2011RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
HospiraHEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.45%heparin sodiumINJECTABLE;INJECTION018916-005Jan 31, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
UBS
Farmers Insurance
Harvard Business School
Moodys
Mallinckrodt
Medtronic
Baxter
Covington
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot